ArticlePlant, cell & environment2026
Shigella Effector VirA Suppresses Plant Immunity by Compromising PRA1.F3-Dependent Accumulation of FLS2 at the Plasma Membrane.
Article in Plant, cell & environment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Surface immune receptors such as flagellin-sensitive 2 (FLS2) are critical for plant defence, and their accumulation at the plasma membrane is tightly controlled by the endomembrane system. Here, we identify the Arabidopsis thaliana prenylated Rab acceptor PRA1.F3 as a positive regulator required for efficient accumulation of FLS2 at the plasma membrane and as a key target of the Shigella type III effector VirA. Although VirA can associate with multiple PRA1 isoforms, immune suppression and enhanced pathogen proliferation in Arabidopsis specifically depend on PRA1.F3. VirA associates with PRA1.F3 at endomembrane compartments and promotes its ubiquitin-proteasome-dependent degradation, leading to reduced FLS2 abundance and attenuation of pattern-triggered immunity. This immune-suppressive activity requires both the GTPase-activating function and membrane association of VirA. In contrast, the closely related isoform PRA1.F4 negatively affects FLS2 accumulation but does not undergo VirA-dependent destabilization. Together, these findings establish PRA1.F3 as a central regulator of immune receptor accumulation and reveal a selective bacterial strategy to subvert host endomembrane regulation and evade immune recognition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.